ECSCR: The Potential Drug Target for Endothelial Cell-Specific Chemotaxis Regulation

Target Name: ECSCR

NCBI ID: G641700

ECSCR

Other Name(s): Endothelial cell-specific chemotaxis regulator (isoform 1) | ARIA | endothelial cell surface expressed chemotaxis and apoptosis regulator | apoptosis regulator through modulating IAP expression | Apoptosis regulator through modulating IAP expression | ECSCR_HUMAN | Endothelial cell-specific chemotaxis regulator | ECSCR variant 1 | Endothelial cell-specific molecule 2 | ECSM2 | Endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant 1 | endothelial cell-specific molecule 2

ECSCR: The Potential Drug Target for Endothelial Cell-Specific Chemotaxis Regulation

Introduction

Endothelial cells play a critical role in maintaining the blood supply and ensuring proper blood flow to various tissues. These specialized cells are responsible for maintaining the tight barrier that separates the blood from the surrounding tissue, as well as participating in the regulation of blood vessel diameter and blood pressure. In addition, endothelial cells are also involved in the production of various signaling molecules that regulate the movement of cells and tissues in the body. One of these signaling molecules is chemotaxis, which is the ability of cells to move towards a specific chemical signal.

ECSR: The Enabler of Endothelial Cell Chemotaxis

The endothelial cell-specific chemotaxis regulator (ECSR) is a protein that plays a crucial role in the regulation of endothelial cell chemotaxis. It is a member of the PIP/TAP (phosphatidylinositol/protein kinase C) signaling pathway, which is a well- established mechanism for the regulation of cell signaling pathways in various organisms.

ECSR functions by interacting with several different signaling pathways, including the PI3K/Akt signaling pathway, the TOR signaling pathway, and the NF-kappa-B signaling pathway. These interactions allow ECSR to regulate the movement of endothelial cells in response to various chemical signals, such as the concentration of chemotactic factors in the surrounding tissue or the presence of other cells.

Drug Targeting ECSR

Drug targeting ECSR is an attractive approach for the development of new treatments for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By inhibiting the activity of ECSR, drugs can reduce the chemotactic activity of endothelial cells, which can lead to therapeutic benefits.

One potential mechanism by which drugs can target ECSR is by inhibiting the interaction between ECSR and its downstream targets. For example, several small molecules have been shown to inhibit the activity of ECSR and prevent it from regulating the movement of endothelial cells. These molecules can include inhibitors of the PI3K/Akt signaling pathway, such as PF-3780, as well as inhibitors of the TOR signaling pathway, such as LY-1011.

Another approach to drug targeting ECSR is to exploit its role as a biomarker. By measuring the level of ECSR in endothelial cells, researchers can monitor the effectiveness of drugs and determine their potential therapeutic benefits. For example, if a drug is shown to inhibit the activity of ECSR, researchers can use techniques such as qRT-PCR to measure the levels of ECSR in endothelial cells and confirm that the drug is having the desired therapeutic effect.

Conclusion

ECSR is a critical regulator of endothelial cell chemotaxis, and its dysfunction has been implicated in various diseases. The development of drugs that target ECSR is an promising approach for the treatment of these diseases and holds great promise for the future of healthcare. By inhibiting the activity of ECSR, drugs can reduce the chemotactic activity of endothelial cells and improve therapeutic outcomes for a variety of diseases. Further research is needed to fully understand the role of ECSR in the regulation of endothelial cell chemotaxis and to develop effective drugs that can target this critical regulator.

Protein Name: Endothelial Cell Surface Expressed Chemotaxis And Apoptosis Regulator

Functions: Regulates endothelial chemotaxis and tube formation. Has a role in angiogenesis and apoptosis via modulation of the actin cytoskeleton and facilitation of proteasomal degradation of the apoptosis inhibitors BIRC3/IAP1 and BIRC2/IAP2

The "ECSCR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ECSCR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets